Site name unknown, Valencia 46009

Phase	Trial	Trial Status	Site Status [desc]	Drug	NCT#
3	Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal Tumors (Resistant at 400 mg Imatinib)	Terminated	Closed	Sunitinib or Imatinib	NCT00372567
2	AMG 655 in Combination With AMG 479 in Advanced, Refractory Solid Tumors	Ongoing, but not recruiting	Closed	AMG 479 + AMG 655	NCT00819169
2	Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib. (OPEN)	Active, not recruiting	Closed	Nilotinib	NCT00756509